Detalhe da pesquisa
1.
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 20(5): 649-662, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948276
2.
Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality.
Lab Invest
; 98(8): 1084-1092, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769698
3.
Management of secondary central nervous system lymphoma.
Br J Haematol
; 200(2): 160-169, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408800
4.
Genetics of Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 379(5): 493, 2018 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30070099
5.
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.
Blood Adv
; 7(5): 845-855, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947123
6.
BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression.
Blood Adv
; 4(14): 3316-3328, 2020 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32717030
7.
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit.
Leukemia
; 34(5): 1329-1341, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31844144
8.
Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.
J Clin Oncol
; 37(3): 202-212, 2019 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523719
9.
Lymphoma: turning biology into cures.
Clin Med (Lond)
; 16(Suppl 6): s125-s129, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27956453